Sr. Manager - Immunology Business Effectiveness BP at Eli Lilly and Company

Shanghai, Shanghai, China

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

At least 5 years of experience in data analysis, sales capability development or a related function within the pharmaceutical industry or in Consulting firms
Minimum 3 years of direct experience in Sales Force Effectiveness or a similar role, with hands-on experience with sales strategy execution, including physician targeting, sales force design and quota setting
Proficiency in Excel and proven ability to deliver performance management reports, sales forecasts, and analytical insights that drive brand performance
Demonstrates strong purpose and alignment with Lilly behaviors and corporate values
Adept at navigating complex, cross-functional environments and driving impactful outcomes
Great sense of responsibility and exceptional communication and influencing skills; capable of dealing with high pressure and partnering effectively with diverse internal stakeholders
Adaptive and open to change, with a mindset geared toward continuous learning and agility
Results-driven, proactive, and committed to challenging the status quo for improvement
Strong analytical thinking and problem-solving capabilities, with the ability to work independently and in teams
Committed to upholding Lilly’s compliance policies and ethical standards
Fluent in both written and spoken English

Responsibilities

Collaborate with the SFE Leader to shape a high-performing, competitive sales force that delivers strong results and value-added services, acting as a key liaison for SFE-related inquiries between BU and CMO. Focus areas include physician targeting, territory alignment, quota setting, and incentive plan communication
Optimize the use of financial and human resources to enhance sales force performance. Continuously assess sales force structure and recommend improvements to BU leadership to drive efficiency and ROI
Foster strong, cross-functional relationships with BU Head, Sales Team, HR, Finance, and other key stakeholders to support SFE initiatives and enable KPI tracking and ensure expansion implementation
Manage the quarterly and annual sales planning cycle (e.g., territory alignment) in partnership with the BU, ensuring timely and high-quality execution
Provide regular sales performance analysis and insights; monitor both business and operational performance
Deliver actionable insights and recommendations to BU leadership regarding execution progress, gaps, and opportunities
Provide independent support to multiple regions on sales force effectiveness topics, such as territory optimization and target setting

Skills

Data Analysis

Sales Capability Development

Physician Targeting

Territory Alignment

Quota Setting

Incentive Compensation

Sales Force Optimization

KPI Tracking

Sales Planning

Sales Performance Analysis

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free